Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
- 1 of 1 copy available at Evergreen Indiana.
0 current holds with 1 total copy.
View other formats and editions
|Location||Call Number / Copy Notes||Barcode||Shelving Location||Status||Due Date|
|Indiana State Library - Indianapolis||ISLM Y 4.G 74/7:114-132 (Text)||2110-1020||Online document||Available||-|
- Physical Description: 1 online resource (iii, 213 pages) : illustrations
- Publisher: Washington : U.S. Government Publishing Office, 2017.
|General Note:|| Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
"Serial no. 114-132."
|Bibliography, etc. Note:|| Includes bibliographical references.
|Source of Description Note:|| Description based on online resource, PDF version; title from title page (FDsys web site, viewed on July 10, 2017).
Search for related items by subject
|Subject:||Prescription pricing > United States.
Pharmaceutical industry > Corrupt practices > United States.
Generic drugs > Government policy > United States.
Drug approval > United States.